Twist Bioscience Corp (NAS:TWST)
$ 46.39 -0.69 (-1.47%) Market Cap: 2.72 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 5.53 GF Score: 85/100

Twist Bioscience Corp at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 04:30PM GMT
Release Date Price: $23.5 (+9.40%)
Tycho W. Peterson
JP Morgan Chase & Co, Research Division - Senior Analyst

Okay. Good morning. We're going to go ahead and get started. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this morning, Twist Bioscience. We'll do a breakout in the Yorkshire room right after. And with that, let me turn it over to Emily.

Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, President, CEO & Director

Thank you very much, Tycho for the introduction and the invitation. Thank you, everybody. It's my pleasure to give you an update on Twist Bioscience. I will start by saying that I will be making some forward-looking statement. So as you may know, at Twist, we write DNA. And we strongly believe that DNA is the molecule of the 21st century. DNA is changing the world now, and our customers are using DNA to change the way chemicals are produced, to change the way food are produced in a way that's more sustainable, change the way drug discovery -- are discovered, the way diagnostics is done and even our DNA is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot